Evermay Wealth Management LLC Has $146,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Evermay Wealth Management LLC grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 298.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,440 shares of the medical device company’s stock after purchasing an additional 1,079 shares during the quarter. Evermay Wealth Management LLC’s holdings in Cooper Companies were worth $146,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after acquiring an additional 17,367,502 shares during the period. Bessemer Group Inc. lifted its stake in shares of Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after acquiring an additional 1,507,049 shares during the period. Champlain Investment Partners LLC lifted its stake in shares of Cooper Companies by 295.3% during the first quarter. Champlain Investment Partners LLC now owns 1,741,120 shares of the medical device company’s stock valued at $176,654,000 after acquiring an additional 1,300,620 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Cooper Companies by 273.8% during the first quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock valued at $175,647,000 after acquiring an additional 1,268,109 shares during the period. Finally, Congress Asset Management Co. MA lifted its stake in shares of Cooper Companies by 252.4% during the first quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock valued at $128,220,000 after acquiring an additional 905,173 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Robert W. Baird upped their price objective on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective on shares of Cooper Companies in a report on Wednesday, July 3rd. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Citigroup upped their price objective on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and upped their price objective for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $111.78.

Cooper Companies Stock Up 0.8 %

NASDAQ COO traded up $0.69 during trading hours on Thursday, hitting $92.68. 1,231,079 shares of the company traded hands, compared to its average volume of 1,130,656. The business’s 50-day moving average is $91.39 and its 200-day moving average is $94.28. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $104.07. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The stock has a market capitalization of $18.45 billion, a price-to-earnings ratio of 54.44, a P/E/G ratio of 2.25 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The firm had revenue of $942.60 million during the quarter, compared to analysts’ expectations of $948.07 million. During the same period in the prior year, the firm posted $0.77 earnings per share. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.